Molecular Diagnostics
New Molecular Imaging Biomarker Effectively Demonstrates Malignant Prostate Tumors
Thomas Jefferson University and NuView Life Sciences have entered into an exclusive licensing agreement for advancing the development of a new molecular imaging compound that identifies genomic expressions linked to prostate cancer. More...22 Jul 2010
In Other News
Blood Test Differentiates Ulcerative Colitis, Crohn's Disease
Diagnosis of Patient's Response to Herceptin to Be Automated
Genetic Markers May Predict Prostate Cancer in Younger Men
Blood Test Detects Abnormalities in Developing Fetus
Short Synthetic Probes Utilized for Bladder Cancer Diagnosis
Ultrasensitive Biosensor Detects Minute Amounts of Proteins
PCR-Based Lung Cancer Reflex Diagnostic Test Validated
Molecular Biology Tests Prevent Transfusion Reactions
Transport Containers Made Safer for Biological Material
Mutation Sequence Licensed for Molecular Diagnostic Products
Cytochrome Genetic Test Helps Provide Better Evidence-Based Treatments
Identification of Malignant Pancreatic Cysts May Lower Cancer Risk
Project Aims To Develop Molecular Diagnostics Solution
Low-Cost, Ultra-Fast DNA Sequencing Technology Developed
Gene Expression Signature Precedes Clinical Multiple Sclerosis
New Lab Technology Aids in Prostate Cancer Treatment
Autism Susceptibility Genes Identified by International Consortium
Genetic Markers Identified for Early Onset Prostate Cancer Risk
Urinary Metabolites Are Different in Autistic Children
Blood-Borne DNA Biomarkers Detect Early Cancer
Stool DNA Testing Could Play Expanded Role in Colon Cancer Prevention
Genetic Biomarker Links Kidney Disease to African Descent
Test Determines Whether Prostate Cancer Returns After Surgery
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.